The field of pediatric rheumatology has seen a decisive change in the way patients are being treated in last few decades. The diseases of this subspeciality be it JIA, SLE, vasculitis or JDM are chronic and require long term term treatment with drugs. The discovery of new drugs including BRMs and intelligent use of older drugs have made it possible to achieve remission in many of these conditions and provide patients with a better quality of life. This chapter highlights the pharmacology, intended uses and possible adverse side effects of many of these drugs. The information provided in this chapter should be a precursor for treating children with rheumatological illness.
|Title of host publication||Pediatric Rheumatology|
|Subtitle of host publication||A Clinical Viewpoint|
|Publisher||Springer Science+Business Media Singapore Private Limited|
|Number of pages||21|
|Publication status||Published - 01-01-2016|
All Science Journal Classification (ASJC) codes